Astrotech Corp

Astrotech Corp (ASTC) Stock Analysis

$7.150

+0.030 (+0.42%)At close

Loading chart…
High
7.520
Open
7.120
VWAP
7.21
Vol
21.33K
Mkt Cap
15.81M
Low
6.964
Amount
153.81K
EV/EBITDA, TTM
0.00

Astrotech Corporation is a spectrometry company, commercializing the Astrotech Mass Spectrometer Technology platform (AMS Technology). The Company's business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., BreathTech Corporation, Pro-Control, Inc., and EN-SCAN, Inc. Astrotech Technologies, Inc. owns and licenses the intellectual property related to AMS Technology. 1st Detect Corporation is a manufacturer of explosives trace detectors and narcotics trace detectors developed for use in security and detection at airports, cargo hubs, military bases, law enforcement centers, and others. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites. Pro-Control, Inc. is focused on applying AMS Technology in industrial process control applications.

AI analysis of Astrotech Corp (ASTC)

sell

Astrotech Corp is not a good buy right now. The current price is $7.15, and the company has a negative forward P/E of 10.21, indicating expected losses. Additionally, the RSI is at 32.93, suggesting the stock is oversold but may not recover soon due to severe financial challenges, including a cash burn of $14.9 million annually against only $1.05 million in revenue.

Valuation Metrics

The current forward P/E ratio for Astrotech Corp (ASTC) is 10.21, compared to its 5-year average forward P/E of 1.07.

Forward P/E

Strongly Overvalued
5Y Average P/E
1.07
Current P/E
10.21
Overvalued
4.17
Undervalued
-2.03

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Undervalued
5Y Average P/S
7.56
Current P/S
0.00
Overvalued
11.80
Undervalued
3.33

Alphio AI Price Scenarios for ASTC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ASTC

$4.99

Scenario price

B

Base

Base · 50%ASTC

$4.92

Scenario price

B

Bear

Bear · 25%ASTC

$4.51

Scenario price

Events Timeline

2026-07-22 (ET)

09:00:00

Astrotech Expands Board to Six Directors

2026-06-30 (ET)

09:00:00

Astrotech Submits $20M Proposal to NASA

2026-06-16 (ET)

09:00:00

Astrotech Explores Sale of 1st Detect Subsidiary

2026-06-03 (ET)

09:50:00

Astrotech Trading Halted Due to Volatility

2026-06-02 (ET)

09:50:00

Astrotech Trading Halted Due to Volatility

News

ASTC FAQ — answered by Alphio AI

Astrotech Corporation is a spectrometry company, commercializing the Astrotech Mass Spectrometer Technology platform (AMS Technology). The Company's business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., BreathTech Corporation, Pro-Control, Inc., and EN-SCAN, Inc. Astrotech Technologies, Inc. owns and licenses the intellectual property related to AMS Technology. 1st Detect Corporation is a manufacturer of explosives trace detectors and narcotics trace detectors developed for use in security and detection at airports, cargo hubs, military bases, law enforcement centers, and others. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites. Pro-Control, Inc. is focused on applying AMS Technology in industrial process control applications. It operates in the Technology sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Astrotech Corp is not a good buy right now. The current price is $7.15, and the company has a negative forward P/E of 10.21, indicating expected losses. Additionally, the RSI is at 32.93, suggesting the stock is oversold but may not recover soon due to severe financial challenges, including a cash burn of $14.9 million annually against only $1.05 million in revenue.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める